Yuki Morimoto

2.7k citations
89 papers · 2.0k indexed · h-index 25

Impact in

Papers in

    • Hepatocellular Carcinoma Treatment and Prognosis 9
    • Bone Tumor Diagnosis and Treatments 7

Yuki Morimoto

85 papers receiving 2.0k citations

Peers

Yuki Morimoto
Comparison fields: 5 of 102
  • Cancer Research 381
  • Immunology and Allergy 153
  • Hepatology 172
  • Pulmonary and Respiratory Medicine 695
  • Oncology 539
Replace Mark C. Wilkes with:
Mark C. Wilkes United States
Jukka Melkko Finland
Michel Bihl Switzerland
Marion Scharpfenecker Netherlands
Iwao Takanami Japan
Gianluigi Arrigoni Italy
Hung Chiang Taiwan
Ursula M. Gehling Germany
Giovanni Ligresti United States
Keith W. Kombrinck United States
Yuki Morimoto relative to Mark C. Wilkes United States Mark C. Wilkes's profile →
Citations per field
00.5×3.5×
Mark C. Wilkes · 1×
Citations per year

Countries citing papers authored by Yuki Morimoto

Since Specialization
Citations

This map shows the geographic impact of Yuki Morimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuki Morimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuki Morimoto more than expected).

Fields of papers citing papers by Yuki Morimoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuki Morimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuki Morimoto. The network helps show where Yuki Morimoto may publish in the future.

Co-authors

The 25 scholars most cited alongside Yuki Morimoto, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yuki Morimoto Line = papers co-authored together Yuki Morimoto links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20241
3 20234
4 20217
5 201997
6 2018158
7 20186
8 201569
9 20121
10 201230
11 201143
12 20118
13 200916
14 20085
15 200526
16 200424
17 200399
18 200224
19 200210
20 200016

About Yuki Morimoto

Yuki Morimoto is a scholar working on Hepatology, Rheumatology, Immunology and Allergy, Pulmonary and Respiratory Medicine and Geriatrics and Gerontology, having authored 89 papers that have together received 2.0k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (20 papers), Hepatocellular Carcinoma Treatment and Prognosis (9 papers), Asthma and respiratory diseases (8 papers), Bone Tumor Diagnosis and Treatments (7 papers), Pancreatic and Hepatic Oncology Research (6 papers), Cardiac tumors and thrombi (6 papers), IL-33, ST2, and ILC Pathways (6 papers) and RNA Interference and Gene Delivery (5 papers). The work is most often cited by research in Cancer Research (381 citations), Immunology and Allergy (153 citations), Hepatology (172 citations), Pulmonary and Respiratory Medicine (695 citations) and Oncology (539 citations). Yuki Morimoto has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Toshifumi Ozaki, Aki Yoshida, Mamoru Ouchida, Kazuhiro Nouso, Kenji Shimizu, Koji Miyahara, Hajime Inoue, Kazuhide Yamamoto, Akira Kawai and Hideaki Kinugasa. Their work appears in journals such as Hepatology Research, Cancer Letters, Journal of Cancer Research and Clinical Oncology, Cancer and Immunity.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026